LSD Coalition Created and Brian Jones is Treasurer

September 26, 2024

LSD Coalition Created and Brian Jones is Treasurer

Testing for Tots founders, Dr Brian and Mrs Tia Jones, are delighted to announce the formation of The Lysosomal Storage Disease Advocacy Coalition (LSDAC). This non-profit coalition of multiple patient advocacy organizations is dedicated to advancing public policy priorities to benefit several communities living with lysosomal storage disorders (LSDs). With Dr Brian Jones serving as treasurer, these are the following organizations who are founding partners:


  • Fabry Support and Information Group (FSIG)
  • National Fabry Disease Foundation
  • Gaucher Community Alliance
  • The MPS Society
  • National Neimann-Pick Foundation
  • Testing for Tots


Aviva Rosenberg, Co-President of the Gaucher Community Alliance will serve as inaugural President and Justin Hopkin of the National Neimann-Pick Foundation will be Vice President. The coalition will focus on:


  • Extending Newborn Screening for Lysosomal Storage Disorders to all 50 States.
  • Introduce and Pass Medicare Home Infusion for LSD Patients.
  • Advocating for increased funding for research into LSDs.
  • Raising awareness of LSDs to Congress and other Stakeholders.


Our goal is to work alongside policymakers, pharmaceutical companies, national medical societies, and other stakeholders to advance policies that benefit and improve the quality of life for current and future patients with LSDs. To join the Lysosomal Storage Disease Advocacy Coalition, please contact Aviva Rosenberg at Aviva@gauchercommunity.org or James Romano at jromano@careandcurepartners.com.

DOWNLOAD FULL ARTICLE
Logo for Candid: Platinum Transparency 2025 in a blue-bordered white square.
November 20, 2025
FSIG Achieves Candid’s Platinum Seal of Transparency
September 26, 2024
LSD Coalition Created and Brian Jones is Treasurer 
September 26, 2024
This September marks the 50th anniversary of newborn screening. Here at the Testing for Tots program, we believe that early detection, diagnosis and intervention can prevent death or disability and enable children to reach their full potential. Rare, and mostly treatable conditions , are screened for within the first 1-2 days after birth. All it takes is a few drops of blood from a heel stick that is then reviewed in the associated laboratory for serious conditions. (The comprehensive newborn screening panel consists of 3 parts – blood test, hearing and pulse oximetry screens). Although these conditions are rare, about 5,000 babies are diagnosed each year with a rare condition. Newborn screening is a critical tool in the belt of the rare disease community. The number of conditions screened vary from state to state. Our team has been working on adding Fabry Disease in multiple states across the nation (Georgia, Massachusetts, South Carolina, Utah, Colorado, Nebraska, and Wisconsin). If you are interested in supporting our initiatives or partnering with us for your home state, email us at testingfortots@gmail.com .